Therapeutics

Senior Scientist, Chemistry - Cidara Therapeutics - San Diego, CA

2 monthes ago   |   By San Diego Biotechnology

Minimum 3 to 5 years of post-graduate experience working in the biotechnology or pharmaceutical industry or a related position as a laboratory scientist.From Cidara Therapeutics - Mon, 02 Dec 2019 22:21:57 GMT - View all San Diego, CA jobs...
Read more ...

 

SEC Reporting Manager - Cidara Therapeutics - San Diego, CA

2 monthes ago   |   By San Diego Biotechnology

Strong organization, time management skills, and attention to detail. At least 5 years of progressive experience in an accounting role.From Cidara Therapeutics - Mon, 02 Dec 2019 22:21:57 GMT - View all San Diego, CA jobs...
Read more ...

 

Clinical Trials Manager - Arcturus Therapeutics - San Diego, CA

2 monthes ago   |   By San Diego Biotechnology

Performing clinical data review of data listings and summary tables, including query generation. A minimum of 6 years of clinical trial experience in...From Indeed - Mon, 02 Dec 2019 20:13:11 GMT - View all San Diego, CA jobs...
Read more ...

 


Search by Tags

   Therapeutics      Pharmaceutical      Pharmaceuticals      Chemistry      Industrial      BioTechnology      San Diego Biotech Jobs      Jobs      Clinical  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

NGM Bio's NASH Drug Shows Promise, Shares Rise on Early Phase 2 Data

NGM Bio's NASH Drug Shows Promise, Shares Rise on Early Phase 2 Data

In what looks to be a transformative year for potential treatments of nonalcoholic steatohepatitis, the liver disease better known as NASH, another biotech has revealed that... Read more ...

Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact

Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact

Genentech is the latest company to enter a drug discovery partnership with Bicycle Therapeutics, adding a new alliance in cancer research for the clinical-stage biotech. Under... Read more ...

UK Reveals Plans For ‘Dynamic' Post-Brexit Regulatory System

UK Reveals Plans For ‘Dynamic' Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing... Read more ...

Esperion's FDA-Approved Cholesterol Drug Priced Even Lower Than Expected

Esperion's FDA-Approved Cholesterol Drug Priced Even Lower Than Expected

As Esperion Therapeutics steered its cholesterol-lowering drug through clinical testing and regulatory review, CEO Tim Mayleben did something unusual for a pharmaceutical... Read more ...

Connecting mathematical models to genomes: Joint estimation of model...

AbstractMotivationParameters of mathematical models used in biology may be genotype-specific and regarded as new traits. Therefore, an accurate estimation of these parameters... Read more ...

Discovering and interpreting transcriptomic drivers of imaging traits using...

AbstractMotivationCancer heterogeneity is observed at multiple biological levels. To improve our understanding of these differences and their relevance in medicine, approaches... Read more ...

Rhapsody: Predicting the pathogenicity of human missense variants

AbstractMotivationThe biological effects of human missense variants have been studied experimentally for decades but predicting their effects in clinical molecular diagnostics... Read more ...

Composite Kernel Association Test for SNP-set Joint Assessment of Genotype...

AbstractIt is of substantial interest to discover novel genetic markers that influence drug response in order to develop personalized treatment strategies that maximize... Read more ...

Neurana Pharmaceuticals to Participate in Cowen Health Care Conference

SAN DIEGO, Feb. 26, 2020 /PRNewswire/ - Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today... Read more ...

Organovo Files Definitive Proxy Statement and Sends Letter to Stockholders

SAN DIEGO--Organovo Holdings, Inc. today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission and has mailed these materials... Read more ...